AmeriDx® Glioblastoma microRNAs Diagnosis Kit, Cat# E20142015 (12 rnxs)
Please sign in so that we can notify you about a reply
AmeriDx® Glioblastoma microRNAs Diagnosis Kit (Cat# E20142015) is designed for quantitative analysis of microRNAs (miRNAs) biomarkers in Glioblastoma development in human blood, Cerebrospinal Fluid (CSF), nasal mucosa or other body fluid, providing diagnosis and therapeutic guidance. The assay is sensitive, accurate and reliable.
Glioblastoma or glioblastoma multiforme (Glioma) is an aggressive cancer that occurs mainly in the central nervous system - the brain or spinal cord. Among them, glioblastoma (GBM) is the most common intracranial primary malignant tumor. At present, the detection methods for diagnosing glioblastoma mainly include neurological function test, functional MRI and magnetic resonance spectroscopy imaging detection, and pathological evaluation (biopsy) of tissue samples. The main problem with these tests is that they are expensive and even require surgical risk. The glioblastoma miRNA rapid detection kit is based on the most advanced scientific research results of glioblastoma basic cancer, which can rapidly and accurately quantitatively detect glioblastoma-specific/abnormal concentrations in blood samples. Small molecule ribonucleic acid (miRNA). Our test kits are not only accurate, but also have unparalleled advantages in terms of cost, risk, and simplification of procedures. Therefore, we also recommend the glioblastoma miRNA rapid detection kit as a tumor marker pre-screening item in the cancer pre-screening package. Glioblastoma, also known as glioblastoma multiforme, is the most common diagnosed brain tumor in central nerve system. Glioblastoma forms from cells called astrocytes that support nerve cells. Glioblastoma can occur at any age but tends to occur more often in older adults. It can cause worsening headaches, nausea, vomiting and seizures.
AmeriDx® Glioblastoma Diagnosis Kit is a miRNA kit including all the necessary reagents for quick and accurate miRNA quantitation in biopsy. Once the miRNA is extracted, a poly(A) tail is added to the 3’ end of miRNA, the miRNA with poly(A) tail is reverse transcribed with oligo(dT)-SP-primer, then SYBR PCR method is employed to quantitatively measure the copy numbers of specific miRNA.